Invenomic Capital Management’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $436K | Sell |
|
|||||
|
2025
Q1 | $940K | Buy |
|
|||||
|
2024
Q4 | $863K | Sell |
|
|||||
|
2024
Q3 | $1.45M | Sell |
|
|||||
|
2024
Q2 | $1.43M | Buy |
|
|||||
|
2024
Q1 | $1.72M | Sell |
|
|||||
|
2023
Q4 | $915K | Sell |
|
|||||
|
2023
Q3 | $764K | Sell |
|
|||||
|
2023
Q2 | $560K | Buy |
|
|||||
|
2023
Q1 | $1.29M | Hold |
|
|||||
|
2022
Q4 | $1.16M | Hold |
|
|||||
|
2022
Q3 | $1.16M | Buy |
|
|||||
|
2022
Q2 | $1.09M | Hold |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $1.45M | Buy |
|
|||||
|
2021
Q3 | $2.21M | Buy |
|
|||||
|
2021
Q2 | $2.22M | Buy |
|
|||||
|
2021
Q1 | $1.66M | Buy |
|